Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder [NA]
A completed clinical trial tested varenicline for smoking cessation in patients with bipolar disorder and nicotine dependence.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation [Phase 2]
Phase 2 study of the TA-NIC vaccine to aid smoking cessation has completed, assessing its efficacy and safety.
-
FDA approval · 2011-05-17FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2011-05-17FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application to market NICORETTE 4MG FRUIT CHILL GUM by Lil' Drug Store Products, Inc. (nicotine polacrilex) for …
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Effects of Varenicline on Brain Activity During Nicotine Abstinence [NA]
A completed study evaluated the effects of varenicline on brain activity during nicotine abstinence, with results posted in May 2011.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: Pilot Study of Tolcapone in Smokers [Phase 2]
A Phase 2 pilot study evaluating tolcapone for nicotine dependence has been completed; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: St. John's Wort for Tobacco Cessation [Phase 2]
A Phase 2 clinical trial evaluated St. John's Wort for tobacco cessation conducted by Mayo Clinic; the study is completed and results were p…
-
FDA approval · 2011-02-17FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for CHANTIX (varenicline tartrate) submitted by Pfizer Laboratories Div Pfizer Inc, updating the…
-
CLINICAL_TRIALS research · 2011-02-15Clinical Trial Update: Effectiveness of Regular Reporting of Spirometric Results on Smoking Quit Rate. [NA]
This clinical trial update assesses whether regular reporting of spirometric results improves smoking quit rates among individuals with nico…
-
FDA approval · 2011-01-21FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for bupropion hydrochloride from BluePoint Laboratories, approving changes to an existing generic pr…
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking [Phase 2]
Phase 2 trial evaluating GW468816, an NMDA glycine site antagonist, for prevention of relapse to smoking; results posted.
-
FDA approval · 2010-12-17FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved Pfizer's supplemental application for CHANTIX (varenicline tartrate).
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking Cessation [Phase 3]
Phase 3 trial comparing the efficacy and safety of rimonabant 20 mg daily versus placebo for smoking cessation.
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US) [Phase 3]
A Phase 3 trial comparing two daily doses of rimonabant (5 mg and 20 mg) to placebo for smoking cessation has completed. The STRATUS US stud…
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers [Phase 2]
Phase 2 trial assessing the efficacy and safety of the Nicotine-Qbeta Vaccine in smokers has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-02Clinical Trial Update: Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation [Phase 3]
Phase 3 clinical trial comparing standard versus extended nicotine patch therapy for smoking cessation; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-11-01Clinical Trial Update: Testing Methylphenidate for Smoking Abstinence [Phase 2]
Phase 2 clinical trial assessing whether methylphenidate supports smoking abstinence; results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch) [Phase 4]
Phase 4 trial update on combined behavioral therapy with naltrexone and a nicotine patch for people with alcohol use disorder and nicotine d…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers [Phase 1, Phase 2]
A combined Phase 1/2 trial assessing weight gain and tolerability of naltrexone and varenicline in smokers.
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation [Phase 2]
Phase 2 trial evaluating combined nortriptyline and a transdermal nicotine patch for smoking cessation; the study has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-06Clinical Trial Update: A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation [Phase 3]
A twelve-week Phase 3 trial comparing varenicline to placebo for smoking cessation demonstrated safety and efficacy. The study was sponsored…
-
FDA approval · 2010-08-30FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride XL (Actavis), a generic extended-release formulation of bupropion hydroc…
-
CLINICAL_TRIALS trial_result · 2010-08-17Clinical Trial Update: Effects of Chantix on Relapse Prevention for Smoking Cessation [Phase 4]
This Phase 4 study evaluates varenicline (Chantix) for relapse prevention in people attempting to quit smoking.
-
FDA approval · 2010-06-29FDA Approved: NICOTROL — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for NICOTROL (nicotine) submitted by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2010-06-17FDA Approved: GOOD NEIGHBOR PHARMACY NICOTINE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for GOOD NEIGHBOR PHARMACY NICOTINE (NICOTINE POLACRILEX) submitted by Amerisource Bergen.